- Filed
- May 10, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Apr 30, 2021 | 286.07M sh |
| Shares Diluted | Q2 2021 · Mar 31, 2021 | 320.11M sh |
| Shares Diluted | Q2 2021 · Mar 31, 2021 | 317.16M sh |
| Shares Diluted | Q2 2021 · Mar 31, 2020 | 282.58M sh |
| Shares Diluted | Q2 2021 · Mar 31, 2020 | 288.21M sh |
| Stock Repurchased | Q2 2021 · Mar 31, 2021 | $0 |
| Stock Repurchased | Q2 2021 · Mar 31, 2020 | $169.22M |
| Capex | Q2 2021 · Mar 31, 2021 | $32.72M |
| Capex | Q2 2021 · Mar 31, 2020 | $31.19M |
| Operating Cash Flow | Q2 2021 · Mar 31, 2021 | $149.62M |
| Operating Cash Flow | Q2 2021 · Mar 31, 2020 | $141.43M |
| Long Term Debt | Q2 2021 · Mar 31, 2021 | $1.56B |
| Long Term Debt | Q2 2021 · Sep 30, 2020 | $1.54B |
| Short Term Debt | Q2 2021 · Mar 31, 2021 | $1.07B |
| Short Term Debt | Q2 2021 · Sep 30, 2020 | $432.21M |
| Cash And Equivalents | Q2 2021 · Mar 31, 2021 | $342.85M |
| Cash And Equivalents | Q2 2021 · Sep 30, 2020 | $301.23M |
| Cash And Equivalents | Q2 2021 · Mar 31, 2020 | $397.91M |
| Cash And Equivalents restated | Q2 2021 · Sep 30, 2018 | $560.96M |
| Current Liabilities | Q2 2021 · Mar 31, 2021 | $1.59B |
| Current Liabilities | Q2 2021 · Sep 30, 2020 | $986.14M |
| Total Liabilities | Q2 2021 · Mar 31, 2021 | $2.37B |
| Total Liabilities | Q2 2021 · Sep 30, 2020 | $2.45B |
| Current Assets | Q2 2021 · Mar 31, 2021 | $782.63M |
| Current Assets | Q2 2021 · Sep 30, 2020 | $735.99M |
| Total Assets | Q2 2021 · Mar 31, 2021 | $3.59B |
| Total Assets | Q2 2021 · Sep 30, 2020 | $3.59B |
| Eps Diluted | Q2 2021 · Mar 31, 2021 | −$0.01 |
| Eps Diluted | Q2 2021 · Mar 31, 2021 | $0.03 |
| Eps Diluted restated | Q2 2021 · Mar 31, 2020 | −$0.07 |
| Eps Diluted restated | Q2 2021 · Mar 31, 2020 | $0.10 |
| Eps Basic | Q2 2021 · Mar 31, 2021 | −$0.01 |
| Eps Basic | Q2 2021 · Mar 31, 2021 | $0.04 |
| Eps Basic restated | Q2 2021 · Mar 31, 2020 | −$0.07 |
| Eps Basic restated | Q2 2021 · Mar 31, 2020 | $0.10 |
| Sga Expense | Q2 2021 · Mar 31, 2021 | $35.75M |
| Sga Expense | Q2 2021 · Mar 31, 2021 | $76.9M |
| Sga Expense restated | Q2 2021 · Mar 31, 2020 | $38.02M |
| Sga Expense restated | Q2 2021 · Mar 31, 2020 | $76.36M |
| Net Income | Q2 2021 · Mar 31, 2021 | −$3.63M |
| Net Income | Q2 2021 · Mar 31, 2021 | $11.26M |
| Net Income restated | Q2 2021 · Mar 31, 2020 | −$20.01M |
| Net Income restated | Q2 2021 · Mar 31, 2020 | $28.68M |
| Operating Income | Q2 2021 · Mar 31, 2021 | $39.85M |
| Operating Income | Q2 2021 · Mar 31, 2021 | $71.4M |
| Operating Income restated | Q2 2021 · Mar 31, 2020 | $11.19M |
| Operating Income restated | Q2 2021 · Mar 31, 2020 | $47.19M |
| Gross Profit | Q2 2021 · Mar 31, 2021 | $220.34M |
| Gross Profit | Q2 2021 · Mar 31, 2021 | $434.31M |
| Gross Profit restated | Q2 2021 · Mar 31, 2020 | $191.87M |
| Gross Profit restated | Q2 2021 · Mar 31, 2020 | $403.67M |
| Cost Of Revenue | Q2 2021 · Mar 31, 2021 | $126.64M |
| Cost Of Revenue | Q2 2021 · Mar 31, 2021 | $258.42M |
| Cost Of Revenue restated | Q2 2021 · Mar 31, 2020 | $124.06M |
| Cost Of Revenue restated | Q2 2021 · Mar 31, 2020 | $273.76M |
| Revenue | Q2 2021 · Mar 31, 2021 | $346.98M |
| Revenue | Q2 2021 · Mar 31, 2021 | $692.73M |
| Revenue restated | Q2 2021 · Mar 31, 2020 | $315.92M |
| Revenue restated | Q2 2021 · Mar 31, 2020 | $677.43M |